HK1211036A1 - Recombinant cell surface capture proteins - Google Patents

Recombinant cell surface capture proteins

Info

Publication number
HK1211036A1
HK1211036A1 HK15111643.1A HK15111643A HK1211036A1 HK 1211036 A1 HK1211036 A1 HK 1211036A1 HK 15111643 A HK15111643 A HK 15111643A HK 1211036 A1 HK1211036 A1 HK 1211036A1
Authority
HK
Hong Kong
Prior art keywords
cell surface
recombinant cell
surface capture
capture proteins
proteins
Prior art date
Application number
HK15111643.1A
Other languages
English (en)
Chinese (zh)
Inventor
‧德施潘德
陳剛
‧布拉科夫
‧凡德爾
‧奧爾德里奇
‧卡馬特
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of HK1211036A1 publication Critical patent/HK1211036A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C07K2317/526—CH3 domain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/64—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a combination of variable region and constant region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
HK15111643.1A 2012-11-14 2015-11-26 Recombinant cell surface capture proteins HK1211036A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261726040P 2012-11-14 2012-11-14
PCT/US2013/069993 WO2014078475A2 (en) 2012-11-14 2013-11-14 Recombinant cell surface capture proteins

Publications (1)

Publication Number Publication Date
HK1211036A1 true HK1211036A1 (en) 2016-05-13

Family

ID=49679651

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15111643.1A HK1211036A1 (en) 2012-11-14 2015-11-26 Recombinant cell surface capture proteins
HK16102584.0A HK1214612A1 (zh) 2012-11-14 2016-03-07 重組的細胞表面捕捉蛋白

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16102584.0A HK1214612A1 (zh) 2012-11-14 2016-03-07 重組的細胞表面捕捉蛋白

Country Status (20)

Country Link
US (3) US9758592B2 (xx)
EP (2) EP2949667B1 (xx)
JP (2) JP6668074B2 (xx)
KR (4) KR20210014766A (xx)
CN (2) CN109485728A (xx)
AR (2) AR093491A1 (xx)
AU (3) AU2013344769B2 (xx)
BR (1) BR112015010758A2 (xx)
CA (2) CA2889541C (xx)
DK (2) DK2920208T3 (xx)
EA (2) EA202190266A1 (xx)
ES (2) ES2817373T3 (xx)
HK (2) HK1211036A1 (xx)
IL (3) IL238176B (xx)
MX (2) MX2015006112A (xx)
PL (2) PL2920208T3 (xx)
SG (2) SG10201804124XA (xx)
TW (3) TWI675044B (xx)
WO (1) WO2014078475A2 (xx)
ZA (1) ZA201502538B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090137416A1 (en) 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
WO2011159847A2 (en) 2010-06-15 2011-12-22 The Regents Of The University Of California Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof
DK3252076T3 (da) 2011-01-14 2019-12-02 Univ California Diagnostisk anvendelse af antistoffer mod ror-1-protein
CN109369808B (zh) 2012-08-24 2023-11-07 加利福尼亚大学董事会 用于治疗ror1癌症并抑制转移的抗体和疫苗
TWI675044B (zh) 2012-11-14 2019-10-21 美商再生元醫藥公司 重組細胞表面捕捉蛋白質
EA038931B9 (ru) * 2014-11-20 2022-02-18 Йиссум Рисерч Дивелопмент Компани Оф Зе Хебрю Юниверсити Оф Иерусалим Лтд. Композиции и способы получения полипептидов с модифицированным профилем гликозилирования в клетках растений
US10520511B2 (en) * 2015-05-12 2019-12-31 Regeneron Pharmaceuticals, Inc. Multimeric protein purity determination
EP3349791A1 (en) 2015-09-15 2018-07-25 Board of Regents, The University of Texas System T-cell receptor (tcr)-binding antibodies and uses thereof
SG10202010155YA (en) 2016-04-20 2020-11-27 Regeneron Pharma Compositions and methods for making antibodies based on use of expression-enhancing loci
BR112018071285A2 (pt) 2016-04-20 2019-02-12 Regeneron Pharma célula, conjunto de vetores, vetor, sistema, e, método
IL299099A (en) 2016-06-27 2023-02-01 Univ California Combinations of cancer treatments
JP7287940B2 (ja) * 2017-03-24 2023-06-06 ランケナウ・インスティテュート・フォー・メディカル・リサーチ ハイブリドーマによって分泌されるモノクローナル免疫グロブリンの誘導性細胞外膜捕捉のための方法及び組成物
CN107177613A (zh) * 2017-07-18 2017-09-19 哈尔滨紫霞生物科技有限公司 一种提高重组猪干扰素‑γ融合蛋白抗病毒活性的方法
JP7425725B2 (ja) * 2017-12-07 2024-01-31 中外製薬株式会社 試料中のポリペプチドの検出または捕捉において使用するための抗体、組成物、および試料中のポリペプチドの検出または捕捉のための方法
WO2020068631A1 (en) * 2018-09-24 2020-04-02 Merck Sharp & Dohme Corp. Expression vectors for eukaryotic expression systems
US20220144916A1 (en) * 2019-02-12 2022-05-12 Board Of Regents, The University Of Texas System High affinity engineered t-cell receptors targeting cmv infected cells
CN114874333A (zh) * 2021-10-18 2022-08-09 深圳科兴药业有限公司 一种生长激素融合蛋白及其应用

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
US5635354A (en) 1991-01-09 1997-06-03 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for describing the repertoires of antibodies (Ab) and of T-cell receptors (TcR) of an individual's immune system
US6080840A (en) 1992-01-17 2000-06-27 Slanetz; Alfred E. Soluble T cell receptors
US6399368B1 (en) 1992-01-17 2002-06-04 Board Of Regents, The University Of Texas System Secretion of T cell receptor fragments from recombinant Escherichia coli cells
ATE237808T1 (de) 1992-10-21 2003-05-15 Stefan Miltenyi Direkte auswahl von zellen durch ein aussheidungsprodukt
US6482655B1 (en) 1993-07-23 2002-11-19 University Of Utah Research Foundation Immunoassay procedure utilizing fluorogenic tracer antigens
US6287784B1 (en) 1993-11-23 2001-09-11 Genentech, Inc. Kinase receptor activation assay
US6410690B1 (en) * 1995-06-07 2002-06-25 Medarex, Inc. Therapeutic compounds comprised of anti-Fc receptor antibodies
HU230048B1 (hu) 1996-02-09 2015-06-29 Abbvie Biotechnology Ltd Humán TNFalfa-kötő antitestek alkalmazása
US5916771A (en) 1996-10-11 1999-06-29 Abgenix, Inc. Production of a multimeric protein by cell fusion method
US6232066B1 (en) 1997-12-19 2001-05-15 Neogen, Inc. High throughput assay system
CA2330678C (en) 1998-05-11 2009-04-07 Miltenyi Biotec Gmbh Method of direct selection of antigen-specific t cells
KR100518958B1 (ko) 1998-05-20 2005-10-06 추가이 세이야쿠 가부시키가이샤 신규한 유전자 클로닝 방법
US6927044B2 (en) 1998-09-25 2005-08-09 Regeneron Pharmaceuticals, Inc. IL-1 receptor based cytokine traps
TR200504220T2 (tr) 1998-12-17 2007-04-24 Biogen Idec Ma Inc. Aktif limfotoksin-beta reseptör imunoglobülin şimeAktif limfotoksin-beta reseptör imunoglobülin şimerik proteinlerinin yüksek düzey ifadesi ve saflaştrik proteinlerinin yüksek düzey ifadesi ve saflaştırılması için bir yöntem.ırılması için bir yöntem.
DE19900635A1 (de) 1999-01-11 2000-07-13 Deutsches Krebsforsch Selektion von monoklonalen Antikörpern
US7138496B2 (en) 2002-02-08 2006-11-21 Genetastix Corporation Human monoclonal antibodies against human CXCR4
US7105348B2 (en) 2000-10-31 2006-09-12 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US20090137416A1 (en) * 2001-01-16 2009-05-28 Regeneron Pharmaceuticals, Inc. Isolating Cells Expressing Secreted Proteins
US20140072979A1 (en) 2001-01-16 2014-03-13 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
EP1392859B1 (en) 2001-01-16 2006-05-10 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
US20140072980A1 (en) 2001-01-16 2014-03-13 Regeneron Pharmaceuticals, Inc. Isolating cells expressing secreted proteins
EP1998266A3 (en) 2001-02-19 2009-02-11 Merck Patent GmbH Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity
PL208712B1 (pl) 2001-08-31 2011-05-31 Avidex Ltd Rozpuszczalny receptor komórek T (sTCR), rozpuszczalna αβ-postać receptora komórek T (sTCR), wielowartościowy kompleks receptora komórek T (TCR), sposób wykrywania kompleksów MHC-peptyd, środek farmaceutyczny zawierający sTCR i/lub wielowartościowy kompleks TCR, cząsteczka kwasu nukleinowego, wektor, komórka gospodarz, sposób otrzymywania całości lub części łańcucha α TCR albo całości lub części łańcucha β TCR, sposób otrzymywania rozpuszczalnego receptora komórek T (sTCR), sposób otrzymywania rozpuszczalnej αβ-postaci receptora komórek T (sTCR) oraz sposób wykrywania kompleksów MHC-peptyd
EP1438400B1 (en) 2001-10-01 2009-06-17 Dyax Corp. Multi-chain eukaryotic display vectors and uses thereof
EP1888649A2 (en) * 2005-05-09 2008-02-20 GlycArt Biotechnology AG Antigen binding molecules having modified fc regions and altered binding to fc receptors
CN101809037B (zh) * 2007-07-31 2014-01-15 瑞泽恩制药公司 人cd20的人抗体及其使用方法
MX2011014008A (es) * 2009-06-26 2012-06-01 Regeneron Pharma Anticuerpos biespecificos facilmente aislados con formato de inmunoglobulina original.
SI2522724T1 (sl) * 2009-12-25 2020-07-31 Chuqai Seiyaku Kabushiki Kaisha Postopek za spremembo polipeptida za čiščenje polipetidnih multimerov
TWI675044B (zh) 2012-11-14 2019-10-21 美商再生元醫藥公司 重組細胞表面捕捉蛋白質

Also Published As

Publication number Publication date
AU2021202371A1 (en) 2021-05-13
JP6668074B2 (ja) 2020-03-18
EP2920208B1 (en) 2020-08-19
SG10201804124XA (en) 2018-07-30
EP2949667A3 (en) 2016-02-24
MX2019015887A (es) 2020-02-07
KR20210014766A (ko) 2021-02-09
TW201439121A (zh) 2014-10-16
EA201590928A1 (ru) 2015-09-30
KR20220025902A (ko) 2022-03-03
JP6856593B2 (ja) 2021-04-07
CN104797598A (zh) 2015-07-22
US9758592B2 (en) 2017-09-12
AR093491A1 (es) 2015-06-10
ZA201502538B (en) 2017-09-27
US20180118852A1 (en) 2018-05-03
TWI745610B (zh) 2021-11-11
PL2920208T3 (pl) 2021-02-08
CA3204343A1 (en) 2014-05-22
IL275270A (en) 2020-07-30
CN104797598B (zh) 2018-12-11
MX2015006112A (es) 2015-08-06
US20210009714A1 (en) 2021-01-14
TW201920289A (zh) 2019-06-01
TWI675044B (zh) 2019-10-21
IL238176A0 (en) 2015-05-31
EP2920208A2 (en) 2015-09-23
EA202190266A1 (ru) 2021-07-30
DK2949667T3 (da) 2020-07-20
ES2817373T3 (es) 2021-04-07
JP2015536345A (ja) 2015-12-21
WO2014078475A3 (en) 2014-11-20
CA2889541A1 (en) 2014-05-22
WO2014078475A2 (en) 2014-05-22
AU2018253474A1 (en) 2018-11-15
KR20150084028A (ko) 2015-07-21
PL2949667T3 (pl) 2020-11-16
AR121002A2 (es) 2022-04-06
CN109485728A (zh) 2019-03-19
KR20230119245A (ko) 2023-08-16
IL275270B (en) 2021-08-31
CA2889541C (en) 2023-07-04
TW202206465A (zh) 2022-02-16
IL285015A (en) 2021-08-31
JP2019023199A (ja) 2019-02-14
AU2013344769B2 (en) 2018-11-15
ES2805526T3 (es) 2021-02-12
EP2949667B1 (en) 2020-05-13
AU2018253474B2 (en) 2021-01-21
BR112015010758A2 (pt) 2017-08-22
AU2013344769A1 (en) 2015-05-21
EP2949667A2 (en) 2015-12-02
EA037546B1 (ru) 2021-04-12
US20140134719A1 (en) 2014-05-15
SG11201502629TA (en) 2015-05-28
DK2920208T3 (da) 2020-09-14
IL238176B (en) 2020-06-30
KR102563030B1 (ko) 2023-08-03
HK1214612A1 (zh) 2016-07-29

Similar Documents

Publication Publication Date Title
IL285015A (en) Recombinant cell surface capture proteins
HRP20190454T1 (hr) Rekombinantni faktor viii proteini
IL291571A (en) cx3cr1 binding polypeptides
HK1209651A1 (en) Cells for producing recombinant iduronate-2-sulfatase -2-
EP2857033A4 (en) SKIN-PUNKING PEPTIDE
GB201220474D0 (en) Polypeptides
EP2812347A4 (en) AUTOPHAGIA-INDUCING PEPTIDE
PL2714888T3 (pl) Rekombinowane drożdże
SG11201404180RA (en) Cho-gmt recombinant protein expression
GB201200555D0 (en) Peptide
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB201223114D0 (en) Novel peptide
EP2891663A4 (en) PEPTIDE DERIVED FROM PSF1
HK1211952A1 (en) Recombinant protein
GB201210286D0 (en) Recombinant polypeptide
GB201112985D0 (en) Polypeptide
GB201112849D0 (en) Polypeptide
GB201106130D0 (en) Polypeptide
GB201203941D0 (en) Polypeptide detection
GB201204065D0 (en) Fusion polypeptide
GB201103967D0 (en) Polypeptide detection
GB201221414D0 (en) Trans-locating peptide
GB201200623D0 (en) Peptide
GB201200624D0 (en) Peptide